Non-alcoholic fatty liver disease (NAFLD) has a growing prevalence in recent years. Its
association with cardiovascular disease has been intensively studied, and certain …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

With the growing prevalence of obesity and diabetes in the United States and across the
world, a rise in the overall incidence and prevalence of non-alcoholic fatty liver disease …

Background and Aims: Whether non-alcoholic fatty liver disease (NAFLD) is associated with
an increased risk of incident chronic kidney disease (CKD) independent of established …

Chronic kidney disease (CKD) in patients with liver cirrhosis has become a new frontier in
hepatology. In recent years, a sharp increase in the diagnosis of CKD has been observed …

Background: NAFLD/NASH is a leading cause of liver diseases. Materials and Methods:
Adult NAFLD/NASH patients were identified retrospectively from MarketScan Commercial …

Context Little is known about the link between nonalcoholic fatty liver disease (NAFLD)
evolution and incident chronic kidney disease (CKD). Objective We aim to assess the …

Methods and Results In this study, we found that SAL alleviated lipid accumulation and
inflammatory response in primary hepatocytes after palmitic acid/oleic acid (PO) stimulation …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver
disease, with an incidence of 20–40% worldwide, making it a major healthcare problem …

The complement system is activated during the development of nonalcoholic fatty liver
disease (NAFLD). We aimed to evaluate the causal relationship between serum C3 and C4 …